Readministration of adenoviral gene delivery to dopamine neurons.
An approach currently being explored as treatment for Parkinson's disease is gene therapy. An important question concerns the duration of transgene expression in dopamine neurons and the issues of vector persistence, neuronal damage and the feasibility of readministering vector to the same neur...
Autors principals: | Gonzalez, S, McMenamin, M, Charlton, H, Goodman, J, Lantos, T, Simpson, C, Wood, M |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2007
|
Ítems similars
-
Neuropathological consequences of delivering an adenoviral vector in the rat brain.
per: McMenamin, M, et al.
Publicat: (2004) -
Local adenoviral expression of Fas ligand upregulates pro-inflammatory immune responses in the CNS.
per: Regardsoe, E, et al.
Publicat: (2004) -
Th1 cytokines are upregulated by adenoviral vectors in the brains of primed mice.
per: Lee, M, et al.
Publicat: (2008) -
Immune responses to adenoviral vectors during gene transfer in the brain.
per: Kajiwara, K, et al.
Publicat: (1997) -
Progress and prospects: Immunobiology of gene therapy for neurodegenerative disease: prospects and risks.
per: McMenamin, M, et al.
Publicat: (2010)